VOCABRIA

This brand name is authorized in Austria, Canada, Estonia, Spain, Finland, France, Croatia, Ireland, Israel, Italy, Japan, Lithuania, Poland, Romania, United States

Active ingredients

The drug VOCABRIA contains one active pharmaceutical ingredient (API):

1 Cabotegravir
UNII 3L12PT535M - CABOTEGRAVIR SODIUM

Cabotegravir inhibits HIV integrase by binding to the integrase active site and blocking the strand transfer step of retroviral deoxyribonucleic acid (DNA) integration which is essential for the HIV replication cycle.

Read about Cabotegravir

Medication package inserts

Below package inserts are available for further reading:

Title Information Source Document Type  
VOCABRIA Prolonged-release suspension for injection European Medicines Agency (EU) MPI, EU: SmPC
VOCABRIA Film-coated tablet FDA, National Drug Code (US) MPI, US: SPL/PLR
VOCABRIA Film-coated tablet European Medicines Agency (EU) MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
J05AJ04 Cabotegravir J Antiinfectives for systemic use → J05 Antivirals for systemic use → J05A Direct acting antivirals → J05AJ Integrase inhibitors
Discover more medicines within J05AJ04

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: CA Health Products and Food Branch Identifier(s): 02497204
Country: EE Ravimiamet Identifier(s): 1835940, 1835951, 1835962
Country: ES Centro de información online de medicamentos de la AEMPS Identifier(s): 1201481001, 1201481003
Country: FI Lääkealan turvallisuus- ja kehittämiskeskus Identifier(s): 104241, 528379
Country: FR Base de données publique des médicaments Identifier(s): 60543082, 67129301
Country: IL מִשְׂרַד הַבְּרִיאוּת Identifier(s): 9045, 9046
Country: IT Agenzia del Farmaco Identifier(s): 049281013, 049281025, 049281037
Country: JP 医薬品医療機器総合機構 Identifier(s): 6250050F1024, 6250408A1028, 6250408A2024
Country: LT Valstybinė vaistų kontrolės tarnyba Identifier(s): 1091692, 1091693, 1091694
Country: PL Rejestru Produktów Leczniczych Identifier(s): 100441698, 100441706, 100441712
Country: RO Agenția Națională a Medicamentului și a Dispozitivelor Medicale Identifier(s): W67282001, W67283001, W67284001
Country: US FDA, National Drug Code Identifier(s): 49702-248

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.